| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/02/2003 | US20030003470 Kit for use in the diagnosis of hypertension; obtain sample, determine pattern of alleles, detect preferential gene expression, preferential gene expression indicates hypertension |
| 01/02/2003 | US20030003462 Novel human interleukin-like proteins and polynucleotides encoding them |
| 01/02/2003 | US20030003461 Truncation selex method |
| 01/02/2003 | US20030003447 Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus |
| 01/02/2003 | US20030003171 Use of the crude extract as anti-spasmodic, anti-arrhythmic and anti-cholinergic agent. |
| 01/02/2003 | US20030003170 Method for the topical treatment and prevention of inflammatory disorders and related conditions using extracts of feverfew (Tanacetum parthenium) |
| 01/02/2003 | US20030003168 Enriched in at least two of the phytochemicals selected from the group consisting of isoflavones, lignans, saponins, catechins and phenolic acids. |
| 01/02/2003 | US20030003166 Comprises N-acetyl cysteine, vitamin A, vitamin B6, deglycyrrhizinated licorice root extract, matricaria chamomile, slipper elm bark, sarsaparilla root, astragalus root, gotu kola leaf extract, and turmeric rhizome extract |
| 01/02/2003 | US20030003163 For restoration and maintenance of gingival and periodontal health; antiplaque/antitar agents; mouthwash |
| 01/02/2003 | US20030003162 Administering a vitamin (ascorbic acid), an amino acid (arginine) and a trace element (magnesium) for treatment of high blood pressure, asthma, glaucoma and tinnitus |
| 01/02/2003 | US20030003155 Microprecipitation method for preparing submicron suspensions |
| 01/02/2003 | US20030003151 Chemical delivery device |
| 01/02/2003 | US20030003150 System for osmotic delivery of pharmaceutically active agents |
| 01/02/2003 | US20030003149 Composition for pulsatile delivery of diltiazem and process of manufacture |
| 01/02/2003 | US20030003147 Effer-vescent bisphosphonate formulation |
| 01/02/2003 | US20030003145 Comprises micronized N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3 -carboxamide |
| 01/02/2003 | US20030003144 Sustained release formulations for nifedipine, dextromethorphan, and danazol |
| 01/02/2003 | US20030003143 Lipidic microparticles linked to multiple proteins |
| 01/02/2003 | US20030003142 Composition and method for the treatment of pigmentation disorders |
| 01/02/2003 | US20030003141 Contacting a blood vessel wall cell with an A beta 40 inhibitor, such that cerebral amyloid angiopathy is inhibited |
| 01/02/2003 | US20030003139 Transdermal system that contains a new highly potent gestagen |
| 01/02/2003 | US20030003132 A mucosal immunoregulatory agent using trehalose as an effective ingredient, which is prepared into foods, beverages and feeds including pet foods |
| 01/02/2003 | US20030003131 Method for manufacture of free-flowing powder containing water-dispersible sterols |
| 01/02/2003 | US20030003130 Compositions for regulating desire for smoking |
| 01/02/2003 | US20030003128 A prosthetic for dental implants comprising a polymeric base material(hydrogel) incorporating at least one active drug and base material releases active drug in a controlled manner when the prosthtic has been implanted in living organism |
| 01/02/2003 | US20030003123 A substance/species active with respect to the trophicity of the cutaneous nerves and/or neurostimulant and/or neuroactivator and/or neuromediator, formulated into cosmetically, or dermatologically acceptable vehicle, diluent |
| 01/02/2003 | US20030003122 Pickering emulsions, comprising an oil phase, a water phase, one type of microfine particles which display both hydrophilic and lipophilic properties, dispersible both in water and in oil, a cyclodextrin and one or more emulsifiers |
| 01/02/2003 | US20030003121 Antiallergic agent |
| 01/02/2003 | US20030003120 A phenolic fraction of fruit obtained from the Rosaceae family, including at least 10% by weight of the sum of phloridzin, chlorogenic acid, epicatechin, quercitrin, procyanidin B2, p-coumaric acid and caffeic acid |
| 01/02/2003 | US20030003119 Topical composition comprising a functionally alkylating cosmetic bonding agent |
| 01/02/2003 | US20030003116 Skin care agent and method of skin care |
| 01/02/2003 | US20030003115 Cosmetics, dermatology |
| 01/02/2003 | US20030003113 Individualized addiction cessation therapy |
| 01/02/2003 | US20030003107 Topical compositions containing probiotic bacillus bacteria, spores, and extracellular products and uses thereof |
| 01/02/2003 | US20030003102 Morpholino imaging and therapy |
| 01/02/2003 | US20030003099 Immunosuppressive combination and its use in the treatment or prophylaxis of insulin-producing cell graft rejection |
| 01/02/2003 | US20030003096 Only specifically binds activated factor VII, and not factor VII, and does not bind to an activated factor VII which is complexed with antithrombin III |
| 01/02/2003 | US20030003095 Activated carbon for preventing pregnancy and sexually transmitted disease |
| 01/02/2003 | US20030003094 Compound which disrupts microtubule function and polymeric carrier, with proviso that polymeric carrier is not a capsule |
| 01/02/2003 | US20030003092 Administering an immunotherapeautic agent in conjunction with a tumour growth restricting agent, in amounts effective to eradicate any advanced or large tumours present |
| 01/02/2003 | US20030003091 Dietary supplement energy-providing to skeletal muscles and protecting the cardiovascular tract |
| 01/02/2003 | US20030003081 A nutritional supplement contains an ubiquinone bound with a glycoprotein matrix |
| 01/02/2003 | US20030003076 Adenovirus E1B-55K single amino acid mutants and methods of use |
| 01/02/2003 | US20030003071 N-methyltaurine as an active ingredient; giving hair fitness and body, and giving hair a feeling of volume |
| 01/02/2003 | US20030003058 Freeze-dried pantoprazole preparation and pantoprazole injection |
| 01/02/2003 | US20030003056 Useful in in vivo applications sucha as embolizing blood vessels and/or reversibly sterilizing mammals |
| 01/02/2003 | US20030003047 Tumor radiotherapy |
| 01/02/2003 | US20030000518 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route |
| 01/02/2003 | EP1271146A1 Method and composition of cellular reprogramming |
| 01/02/2003 | EP1270737A1 Preincubation assay method |
| 01/02/2003 | EP1270599A1 Salmon-origin chondroitin sulfate |
| 01/02/2003 | EP1270584A1 Glucopyranosyloxy benzylbenzene derivatives, medicinal compositions containing the same and intermediates for the preparation of the derivatives |
| 01/02/2003 | EP1270580A1 Antimicrobial acesulfame complexes, their preparation and their use |
| 01/02/2003 | EP1270579A1 Process for producing camptothecin |
| 01/02/2003 | EP1270577A1 Furoisoquinoline derivatives, process for producing the same and use thereof |
| 01/02/2003 | EP1270576A2 3-phenyl-3,7-diazabicyclo[3,3,1]nonanes, process for their preparation and pharmaceutical compositions containing them |
| 01/02/2003 | EP1270574A1 Caffeine complexes with improved flavour, process for their preparation and their use |
| 01/02/2003 | EP1270572A1 Condensed pyrazole derivatives, process for producing the same and use thereof |
| 01/02/2003 | EP1270567A1 Pyrazoline derivatives or tetrahydropyridazine derivatives and medicinal use thereof |
| 01/02/2003 | EP1270565A1 4-Substituted furan-2-sulfonamide and its use in the preparation of sulfonyl urea derivatives |
| 01/02/2003 | EP1270562A2 Cyclic alpha-amino-gamma-hydroxy-amides, process for their preparation and pharmaceutical compositions thereof |
| 01/02/2003 | EP1270560A1 Hiv replication inhibiting pyrimidines |
| 01/02/2003 | EP1270559A1 Novel imidazole derivatives with anti-inflammatory activity |
| 01/02/2003 | EP1270558A1 "Compound for the treatment of atherosclerotic-thrombotic pathological conditions" |
| 01/02/2003 | EP1270555A1 Method for oxidizing a thioether group into a sulfoxide group |
| 01/02/2003 | EP1270554A1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity |
| 01/02/2003 | EP1270551A1 Urea derivatives with antiproteolytic activity |
| 01/02/2003 | EP1270032A1 Device for parenterally delivering solid drug compositions |
| 01/02/2003 | EP1270026A1 Stents comprising vitamin D analogues for restenosis inhibition |
| 01/02/2003 | EP1270017A1 Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases |
| 01/02/2003 | EP1270015A2 A complex comprising OCIF and Polysaccharide |
| 01/02/2003 | EP1270008A2 Fused tricyclic analogues of guanosine for treating tumors |
| 01/02/2003 | EP1270007A2 Microemulsions for the transdermal administration of apomorphine, for the treatment of Parkinson's disease |
| 01/02/2003 | EP1270006A2 Quinolone derivative pharmaceutical composition and production method therefor |
| 01/02/2003 | EP1270005A2 Formulation comprising amoxicillin and an organic acid |
| 01/02/2003 | EP1270004A1 Diuretics containing gamma-tocotrienol |
| 01/02/2003 | EP1270002A2 Pharmaceutical compositions for preventing problem behaviour of companion animals |
| 01/02/2003 | EP1270001A1 Pharmaceutical composition containing calcium acetate and calcium carbonate |
| 01/02/2003 | EP1270000A2 Benzoic acid substituted benzopyrans for the treatment of atherosclerosis |
| 01/02/2003 | EP1269999A1 Ultraviolet-shielding adhesive preparation |
| 01/02/2003 | EP1269998A1 Composition of prolonged liberation in the form of multiple granules that enables the maintenance of the therapeutic action of 4-nitro-2-phenoximethanesulfonanilide |
| 01/02/2003 | EP1269997A1 Unit dosage comprising amoxicillin and clavulanate |
| 01/02/2003 | EP1269996A1 Unit dosage comprising amoxycillin and clavulanate |
| 01/02/2003 | EP1269994A2 Pharmaceutical compositions comprising drug and concentration-enhancing polymers |
| 01/02/2003 | EP1269992A1 Compositions comprising quaternary ammonium compounds |
| 01/02/2003 | EP1269989A1 Cosmetic or dermatological composition comprising acylaminoamide derivatives |
| 01/02/2003 | EP1269988A1 Cosmetic or dermatological composition comprising acylaminoamide derivatives |
| 01/02/2003 | EP1269986A2 Compositions comprising a compound of low solubility and a lipophilic amino acid derivative, and corresponding uses and processes |
| 01/02/2003 | EP1269984A1 Cosmetic and/or dermatological andor pharmaceutical composition for topical application containing at least one compound inhibiting 3-beta-HSD enzyme |
| 01/02/2003 | EP1269983A1 Use of 1,2-Decanediol against germs which cause body malodour |
| 01/02/2003 | EP1269973A1 Hair growth stimulant compositions |
| 01/02/2003 | EP1269860A1 Pharmaceutical composition |
| 01/02/2003 | EP1269845A1 Bacterial growth regulators or inhibitors with the use of 1,5-d-anhydrofructose |
| 01/02/2003 | EP1269191A1 Docosahexaenoic acid as retinoid x receptor and uses thereof |
| 01/02/2003 | EP1269183A1 Assay for agents that induce chemokinesis |
| 01/02/2003 | EP1268861A2 Diagnosis of diseases associated with dna transcription |
| 01/02/2003 | EP1268857A2 Diagnosis of diseases associated with gene regulation |
| 01/02/2003 | EP1268855A2 Diagnosis of diseases associated with tumor suppressor genes and oncogenes |
| 01/02/2003 | EP1268854A1 High specificity marker detection |
| 01/02/2003 | EP1268839A1 Beta-glucans from filamentous fungi |